These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15764173)

  • 41. Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
    Aller AI; Claro R; Castro C; Serrano C; Colom MF; Martín-Mazuelos E
    Chemotherapy; 2007; 53(4):300-5. PubMed ID: 17496416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
    Espinel-Ingroff A; Johnson E; Hockey H; Troke P
    J Antimicrob Chemother; 2008 Mar; 61(3):616-20. PubMed ID: 18222957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
    Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antifungal activity of fluconazole and voriconazole against non-Candida yeasts and yeast-like fungi clinical isolates.
    Mandras N; Roana J; Scalas D; Fucale G; Allizond V; Banche G; Barbui A; Li Vigni N; Newell VA; Cuffini AM; Tullio V
    New Microbiol; 2015 Oct; 38(4):583-7. PubMed ID: 26485018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA; Diekema DJ; Colombo AL; Kibbler C; Ng KP; Gibbs DL; Newell VA
    J Clin Microbiol; 2006 Oct; 44(10):3578-82. PubMed ID: 17021085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
    Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
    Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
    Mann PA; McNicholas PM; Chau AS; Patel R; Mendrick C; Ullmann AJ; Cornely OA; Patino H; Black TA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5026-34. PubMed ID: 19786600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
    Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
    Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
    Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
    Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies.
    Safdar A; Armstrong D
    Bone Marrow Transplant; 2002 Dec; 30(12):931-5. PubMed ID: 12476287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
    Kostiala AA; Kostiala I
    J Med Microbiol; 1984 Oct; 18(2):249-54. PubMed ID: 6387127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints.
    Gamaletsou MN; Daikos GL; Walsh TJ; Perlin DS; Ortigosa CJ; Psaroulaki A; Pagoni M; Argyropoulou A; Nepka M; Perivolioti E; Kotsopoulou M; Perloretzou S; Marangos M; Kofteridis D; Grammatikou M; Goukos D; Petrikkos G; Sipsas NV
    Int J Antimicrob Agents; 2014 Sep; 44(3):248-55. PubMed ID: 25108876
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Tonui J; Mureithi M; Jaoko W; Bii C
    Pan Afr Med J; 2021; 38():227. PubMed ID: 34046132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies].
    Ji Y; Xu LP; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):473-7. PubMed ID: 23827099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole.
    Stevens DA; Aristizabal BH
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):103-6. PubMed ID: 9368086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluconazole for antifungal prophylaxis in chemotherapy-induced neutropenia.
    Preston SL; Briceland LL
    Am J Health Syst Pharm; 1995 Jan; 52(2):164-73; quiz 205-6. PubMed ID: 12879543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral antifungals as prophylaxis in haematological malignancy.
    Prentice AG; Donnelly P
    Blood Rev; 2001 Mar; 15(1):1-8. PubMed ID: 11333134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.